Table 4.
Symptoms of participants who did not complete the minimum of 80% of treatment.
| Group | GLG (n = 5) | PG (n = 5) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Participants | P1 | P2 | P3 | P4 | P5 | P1 | P2 | P3 | P4 | P5 |
| Ingested doses before withdrawal | 30 | 30 | 50 | 52 | 58 | 3 | 4 | 26 | 32 | 67 |
| Symptoms | ||||||||||
| Stomach problems (pain, acidity, burning, cramp and not specified discomfort) | x | x | x | x | x | x | x | x | x | |
| Nausea and vomiting | x | x | x | x | x | x | x | |||
| Diarrhea | x | x | x | |||||||
| Dyspepsia | x | |||||||||
| Meteorism | x | x | ||||||||
| Agitation | x | |||||||||
| Dehydration and swelling | x | |||||||||
| Headache | x | |||||||||
| Hypertension | x | |||||||||
| Itching and irritation | x | |||||||||
GLG: Ganoderma lucidum group; PG: placebo group. P: participant; x: presence of a specific discomfort.